Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Axovant Sciences Gmbh patents

Recent patent applications related to Axovant Sciences Gmbh. Axovant Sciences Gmbh is listed as an Agent/Assignee. Note: Axovant Sciences Gmbh may have other listings under different names/spellings. We're not affiliated with Axovant Sciences Gmbh, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Axovant Sciences Gmbh-related inventors

Methods of maintaining, treating or improving cognitive function

A method of administering an effective amount of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.. . ... Axovant Sciences Gmbh

Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline

The combination of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or a pharmaceutically acceptable salt thereof with a second therapeutic agent, and its use for the treatment of a) psychiatric disorders with prominent cognitive deficits e.g. Chronic ptsd (post traumatic stress disorder); b) non-degenerative disorders with prominent cognitive deficits e.g. ... Axovant Sciences Gmbh

Compositions and methods of treating a neurodegenerative disease

The present application relates to novel compositions useful for the treatment of a neurodegenerative disease and uses thereof. The present application also relates to novel compositions and methods for the reduction of side effects in a subject being treated for a neurodegenerative disease. ... Axovant Sciences Gmbh

Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotonic acetylcholine receptors

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nachr, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.. ... Axovant Sciences Gmbh

Methods of improving balance, gait or both in patients with neurological disease

Disclosed herein are compositions and methods for reducing the frequency of falls, improving balance, improving gait, or some combination thereof in subjects with neurodegenerative disease.. . ... Axovant Sciences Gmbh

Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease

The present invention relates to certain pyrazole derivatives of formula (i) and pharmaceutical compositions thereof that modulate the activity of the 5-ht2a serotonin receptor and their uses for the treatment and prophylaxis of visual hallucinations associated with lewy body dementia.. . ... Axovant Sciences Gmbh

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Axovant Sciences Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Axovant Sciences Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by